Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,060.75
    -9.80 (-0.19%)
     

  • Dow

    38,365.92
    -137.77 (-0.36%)
     

  • Nasdaq

    15,716.86
    +20.22 (+0.13%)
     

  • Bitcoin USD

    65,123.84
    -1,660.02 (-2.49%)
     

  • CMC Crypto 200

    1,406.05
    -18.05 (-1.27%)
     

  • FTSE 100

    8,039.24
    -5.57 (-0.07%)
     

  • Gold

    2,348.30
    +6.20 (+0.26%)
     

  • Crude Oil

    82.81
    -0.55 (-0.66%)
     

  • 10-Yr Bond

    4.6600
    +0.0620 (+1.35%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Novo Nordisk Settles Securities Lawsuit in Denmark

Investing.com
·1-min read

By Sam Boughedda

Investing.com — Novo Nordisk A/S (NYSE:NVO) said Friday that it has settled a securities lawsuit in Denmark.

Shares of Novo fell 3% in midday trading.

The company said the settlement contained no admission of liability, wrongdoing or responsibility and Novo Nordisk is not making any payment.

The 2019 lawsuit alleged the company made misleading statements and did not make appropriate disclosures regarding its insulin business in the United States.

The lawsuit was filed by several shareholders claiming compensation worth 11.785 billion Danish crowns or approximately $1.75 billion.

At the time, Novo said it "disagrees with the allegations and is prepared to defend the company in this matter."

ADVERTISEMENT

Related Articles

Novo Nordisk Settles Securities Lawsuit in Denmark

S&P 500 Falls After Bank Earnings Fail to Impress

Nearly 90% of big US meat plants had COVID-19 cases in pandemic’s first year - data